• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.

作者信息

Cho Maria, Nonomura Yumi, Kaku Yo, Nakabo Shuichiro, Endo Yuichiro, Otsuka Atsushi, Kabashima Kenji

机构信息

Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

J Dermatol. 2019 Jan;46(1):e43-e44. doi: 10.1111/1346-8138.14492. Epub 2018 Jun 4.

DOI:10.1111/1346-8138.14492
PMID:29863795
Abstract
摘要

相似文献

1
Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.与纳武单抗治疗恶性黑色素瘤相关的硬皮病样综合征。
J Dermatol. 2019 Jan;46(1):e43-e44. doi: 10.1111/1346-8138.14492. Epub 2018 Jun 4.
2
Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients.抗程序性细胞死亡-1治疗下的白癜风与黑色素瘤患者生存率提高相关。
J Am Acad Dermatol. 2020 Mar;82(3):770-772. doi: 10.1016/j.jaad.2019.11.017. Epub 2019 Nov 14.
3
New onset of psoriasis during nivolumab treatment for lung cancer.在使用纳武单抗治疗肺癌期间新发银屑病。
J Dermatol. 2018 Mar;45(3):e55-e56. doi: 10.1111/1346-8138.14167. Epub 2017 Dec 4.
4
Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.纳武单抗诱发晚期恶性黑色素瘤患者出现缓解性血清阴性对称性滑膜炎伴凹陷性水肿（RS3PE）综合征的病例
J Dermatol. 2017 Aug;44(8):e196-e197. doi: 10.1111/1346-8138.13840. Epub 2017 Apr 9.
5
Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma.在一名黑色素瘤患者接受纳武单抗治疗期间，无晕良性黑素细胞痣中免疫反应的诱导。
JAMA Dermatol. 2017 Aug 1;153(8):832-834. doi: 10.1001/jamadermatol.2017.0615.
6
Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.与纳武单抗相关的转移性恶性黑色素瘤放射性回忆性皮炎
Int J Dermatol. 2017 Apr;56(4):e75-e77. doi: 10.1111/ijd.13513. Epub 2017 Jan 19.
7
Toxic epidermal necrolysis accompanied by several immune-related adverse events developed after discontinuation of nivolumab.停用纳武单抗后发生了伴有多种免疫相关不良事件的中毒性表皮坏死松解症。
Eur J Cancer. 2020 May;131:1-4. doi: 10.1016/j.ejca.2020.02.044. Epub 2020 Apr 2.
8
Bullous pemphigoid induced by ipilimumab in a patient with metastatic malignant melanoma after unsuccessful treatment with nivolumab.一名转移性恶性黑色素瘤患者在使用纳武单抗治疗失败后，因使用伊匹单抗诱发大疱性类天疱疮。
J Dermatol. 2018 Jan;45(1):e21-e22. doi: 10.1111/1346-8138.14043. Epub 2017 Sep 25.
9
Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.与伊匹单抗和纳武单抗相关的急性泛发性脓疱性皮病
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e256-e257. doi: 10.1111/jdv.14282. Epub 2017 May 30.
10
No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.一名转移性黑色素瘤患者改用伊匹单抗后，未再出现纳武单抗诱导的特发性血小板减少性紫癜复发。
Eur J Dermatol. 2018 Feb 1;28(1):84-85. doi: 10.1684/ejd.2017.3151.

引用本文的文献

1
Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review.接受帕博利珠单抗联合常规化疗的患者出现硬皮病样皮损：病例报告及文献复习。
Medicina (Kaunas). 2024 Jul 3;60(7):1092. doi: 10.3390/medicina60071092.
2
Immune Checkpoint Inhibitor-Associated Systemic Sclerosis in the Treatment of a Small Cell Lung Cancer Patient with Durvalumab: A Case Report.度伐利尤单抗治疗小细胞肺癌患者时出现免疫检查点抑制剂相关的系统性硬化症：一例报告
Clin Cosmet Investig Dermatol. 2024 Mar 18;17:663-669. doi: 10.2147/CCID.S451386. eCollection 2024.
3
Scleroderma Secondary to Pembrolizumab: A Case Report and Review of 19 Cases of Anti-PD-1-Induced Scleroderma.
帕博利珠单抗继发硬皮病：一例报告及19例抗PD-1诱导的硬皮病病例回顾
Case Rep Oncol. 2023 Sep 6;16(1):846-856. doi: 10.1159/000533373. eCollection 2023 Jan-Dec.
4
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics.检查点抑制剂相关的硬皮病及硬皮病样疾病
Pharmaceuticals (Basel). 2023 Feb 8;16(2):259. doi: 10.3390/ph16020259.
5
Cutaneous manifestations associated with immune checkpoint inhibitors.与免疫检查点抑制剂相关的皮肤表现。
Front Immunol. 2023 Feb 20;14:1071983. doi: 10.3389/fimmu.2023.1071983. eCollection 2023.
6
A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin.1例由纳武单抗引起的硬皮病样综合征经静脉注射免疫球蛋白成功治疗。
JAAD Case Rep. 2022 Jun 22;31:76-79. doi: 10.1016/j.jdcr.2022.06.007. eCollection 2023 Jan.
7
Skin Manifestation Induced by Immune Checkpoint Inhibitors.免疫检查点抑制剂诱导的皮肤表现
Clin Cosmet Investig Dermatol. 2022 May 10;15:829-841. doi: 10.2147/CCID.S364243. eCollection 2022.
8
Scleroderma-like syndrome associated with pembrolizumab.与帕博利珠单抗相关的硬皮病样综合征。
J Scleroderma Relat Disord. 2020 Jun;5(2):NP5-NP6. doi: 10.1177/2397198320905192. Epub 2020 Feb 18.
9
Atezolizumab-induced scleroderma: a rare complication.阿特珠单抗引起的硬皮病：一种罕见的并发症。
BMJ Case Rep. 2021 Nov 11;14(11):e244968. doi: 10.1136/bcr-2021-244968.
10
Cancer and Scleroderma.癌症和硬皮病。
Rheum Dis Clin North Am. 2020 Aug;46(3):551-564. doi: 10.1016/j.rdc.2020.03.002. Epub 2020 Jun 10.